Allogene Therapeutics (ALLO) Free Cash Flow (2018 - 2026)
Allogene Therapeutics recorded quarterly Free Cash Flow of -$12.9 million in Q1 2026, up 52.7% quarter-over-quarter from -$27.3 million in Q4 2025, and up 75.59% year-over-year from -$7.4 million in Q1 2025.
Allogene Therapeutics' Free Cash Flow history runs 9 years deep, the most recent figure standing at -$12.9 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 75.59% year-over-year to -$12.9 million; the TTM figure through Mar 2026 stood at -$109.3 million (up 44.78% YoY), while the FY2025 annual figure was -$149.4 million, up 25.69% from the prior year.
- Free Cash Flow came in at -$12.9 million for Q1 2026 at Allogene Therapeutics, up from -$27.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$12.9 million in Q1 2026 to a low of -$70.1 million in Q1 2022.
- A 5-year average of -$48.5 million and a median of -$52.9 million in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow plunged 124.09% in 2022 and jumped 75.59% in 2026, its largest moves.
- Allogene Therapeutics' Free Cash Flow stood at -$59.3 million in 2022, then gained by 9.09% to -$53.9 million in 2023, then surged by 31.42% to -$37.0 million in 2024, then advanced by 26.07% to -$27.3 million in 2025, then soared by 52.7% to -$12.9 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$12.9 million, -$27.3 million, and -$29.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Allogene Therapeutics | 521.43 Mn | 521.43 Mn | - | -12.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.92 Mn |
| Mar 31, 2026 | -12.92 Mn |
| Dec 31, 2025 | -27.32 Mn |
| Dec 31, 2025 | -27.32 Mn |
| Sep 30, 2025 | -29.86 Mn |
| Sep 30, 2025 | -29.86 Mn |
| Jun 30, 2025 | -39.25 Mn |
| Jun 30, 2025 | -39.25 Mn |
| Mar 31, 2025 | -52.93 Mn |
| Mar 31, 2025 | -52.93 Mn |
| Dec 31, 2024 | -36.96 Mn |
| Dec 31, 2024 | -36.96 Mn |
| Sep 30, 2024 | -44.54 Mn |
| Sep 30, 2024 | -44.54 Mn |
| Jun 30, 2024 | -63.59 Mn |
| Jun 30, 2024 | -63.59 Mn |
| Mar 31, 2024 | -55.91 Mn |
| Mar 31, 2024 | -55.91 Mn |
| Dec 31, 2023 | -53.89 Mn |
| Dec 31, 2023 | -53.89 Mn |
| Sep 30, 2023 | -55.54 Mn |
| Sep 30, 2023 | -55.54 Mn |
| Jun 30, 2023 | -62.15 Mn |
| Jun 30, 2023 | -62.15 Mn |
| Mar 31, 2023 | -67.67 Mn |
| Mar 31, 2023 | -67.67 Mn |
| Dec 31, 2022 | -59.28 Mn |
| Dec 31, 2022 | -59.28 Mn |
| Sep 30, 2022 | -47.88 Mn |
| Sep 30, 2022 | -47.88 Mn |
| Jun 30, 2022 | -43.91 Mn |
| Jun 30, 2022 | -43.91 Mn |
| Mar 31, 2022 | -70.14 Mn |
| Mar 31, 2022 | -70.14 Mn |
| Dec 31, 2021 | -26.45 Mn |
| Dec 31, 2021 | -26.45 Mn |
| Sep 30, 2021 | -52.23 Mn |
| Sep 30, 2021 | -52.23 Mn |
| Jun 30, 2021 | -50.23 Mn |
| Jun 30, 2021 | -50.23 Mn |
| Mar 31, 2021 | -57.63 Mn |
| Mar 31, 2021 | -57.63 Mn |
| Dec 31, 2020 | 30.01 Mn |
| Dec 31, 2020 | 30.01 Mn |
| Sep 30, 2020 | -57.84 Mn |
| Sep 30, 2020 | -57.84 Mn |
| Jun 30, 2020 | -42.78 Mn |
| Jun 30, 2020 | -42.78 Mn |
| Mar 31, 2020 | -53.06 Mn |
| Mar 31, 2020 | -53.06 Mn |
| Dec 31, 2019 | -18.26 Mn |
| Dec 31, 2019 | -18.26 Mn |
| Sep 30, 2019 | -50.34 Mn |
| Sep 30, 2019 | -50.34 Mn |
| Jun 30, 2019 | -38.04 Mn |
| Jun 30, 2019 | -38.04 Mn |
| Mar 31, 2019 | -35.39 Mn |
| Mar 31, 2019 | -35.39 Mn |
| Dec 31, 2018 | -24.51 Mn |
| Dec 31, 2018 | -24.51 Mn |
| Sep 30, 2018 | -17.27 Mn |
| Sep 30, 2018 | -17.27 Mn |
| Jun 30, 2018 | -6.11 Mn |
| Jun 30, 2018 | -6.11 Mn |
| Mar 31, 2018 | 5,000.00 |
| Mar 31, 2018 | 5,000.00 |